Page 12 - Genome Engineering News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The latest advances in Gene Editing & CRISPR technology. Discover exclusive interviews and free resource

Company On-track to Submit First IND for BEAM-101 in the Second Half of 2021 Continued Progress Across Base Editing Portfolio, Including Initiation of...

MIT neuroscientist Guoping Feng has developed a new gene-editing method that may lead to the development of safer, more efficient gene therapies.

The Factors such as a wide range of applications of synthetic biology, the rising R&D funding and growing initiatives in synthetic biology, declining cost of DNA sequencing and synthesizing, and increasing investments in the market are propelling the growth of this market. However, biosafety, biosecurity, and ethical concerns related to synthetic biology would hamper the growth of this market. The oligonucleotides and synthetic DNA segment accounted for the largest share of the tool segment in the synthetic biology market in 2020. On the basis of tool, the market is broadly segmented into oli...

A groundbreaking study led by engineering and medical researchers at the University of Minnesota Twin Cities shows how engineered immune cells used in new cancer therapies can overcome physical barriers to allow a patient's own immune system to fight tumors.